solifenacin succinate (VESIcare)
Sponsors
University of South Florida
Conditions
Overactive Bladder in Parkinson's DiseaseParkinson's DiseaseUrinary Incontinence
Phase 4
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease
WithdrawnNCT00584090
Start: 2007-11-30Updated: 2012-12-03
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
CompletedNCT01018264
Start: 2010-01-31End: 2014-08-31Updated: 2021-11-09